# Amrep Corp.: overview AXR · NYSE · CIK 6207 · [Real estate](/sectors/real-estate.md) · fiscal year ends Apr 30 Pages: [Overview](/companies/axr.md) · [Financials](/companies/axr/financials.md) · [Filings](/companies/axr/filings.md) · [Insiders](/companies/axr/insiders.md) Latest reported revenue: [$6.1m](/filings/0001104659-26-107084.md) for Q1 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-107084). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [11.9](/filings/0001104659-25-120644.md) | [7.5](/filings/0001104659-26-027088.md) | [11.2 d](/filings/0001104659-26-086659.md) | [17.9](/filings/0001104659-26-107084.md) | [9.4](/filings/0001104659-25-120644.md) | [14.6](/filings/0001104659-26-027088.md) | [11.0 d](/filings/0001104659-26-086659.md) | [6.1](/filings/0001104659-26-107084.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [26.4%](/filings/0001104659-25-120644.md) | [5.7%](/filings/0001104659-26-027088.md) | [31.7% d](/filings/0001104659-26-086659.md) | [34.4%](/filings/0001104659-26-107084.md) | [11.9%](/filings/0001104659-25-120644.md) | [20.6%](/filings/0001104659-26-027088.md) | [19.2% d](/filings/0001104659-26-086659.md) | [(2.7%)](/filings/0001104659-26-107084.md) | | Net margin | % | [33.9%](/filings/0001104659-25-120644.md) | [9.5%](/filings/0001104659-26-027088.md) | [34.8% d](/filings/0001104659-26-086659.md) | [26.3%](/filings/0001104659-26-107084.md) | [12.8%](/filings/0001104659-25-120644.md) | [21.6%](/filings/0001104659-26-027088.md) | [11.3% d](/filings/0001104659-26-086659.md) | [4.6%](/filings/0001104659-26-107084.md) | | Diluted EPS | $ per share | [0.75](/filings/0001104659-25-120644.md) | [0.13](/filings/0001104659-26-027088.md) | not reported | [0.87](/filings/0001104659-26-107084.md) | [0.22](/filings/0001104659-25-120644.md) | [0.58](/filings/0001104659-26-027088.md) | not reported | [0.05](/filings/0001104659-26-107084.md) | | Free cash flow | $m | [(0.3) d](/filings/0001104659-25-120644.md) | [(3.3) d](/filings/0001104659-26-027088.md) | [2.5 d](/filings/0001104659-26-086659.md) | [9.5](/filings/0001104659-26-107084.md) | [(4.3) d](/filings/0001104659-25-120644.md) | [5.4 d](/filings/0001104659-26-027088.md) | [2.2 d](/filings/0001104659-26-086659.md) | [(3.6)](/filings/0001104659-26-107084.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-04-30) | FY2023 (2023-04-30) | FY2024 (2024-04-30) | FY2025 (2025-04-30) | FY2026 (2026-04-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [58.9](/filings/0001410578-23-001494.md) | [48.7](/filings/0001410578-24-001102.md) | [51.4](/filings/0001410578-25-001515.md) | [49.7](/filings/0001104659-26-086659.md) | [52.8](/filings/0001104659-26-086659.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [36.2%](/filings/0001410578-23-001494.md) | [12.0%](/filings/0001410578-24-001102.md) | [14.8%](/filings/0001410578-25-001515.md) | [24.4%](/filings/0001104659-26-086659.md) | [23.4%](/filings/0001104659-26-086659.md) | | Net margin | % | [26.9%](/filings/0001410578-23-001494.md) | [44.8%](/filings/0001410578-24-001102.md) | [13.0%](/filings/0001410578-25-001515.md) | [25.6%](/filings/0001104659-26-086659.md) | [19.5%](/filings/0001104659-26-086659.md) | | Diluted EPS | $ per share | [2.21](/filings/0001410578-23-001494.md) | [4.11](/filings/0001410578-24-001102.md) | [1.25](/filings/0001410578-25-001515.md) | [2.37](/filings/0001104659-26-086659.md) | [1.91](/filings/0001104659-26-086659.md) | | Free cash flow | $m | [14.2](/filings/0001410578-23-001494.md) | [6.3](/filings/0001410578-24-001102.md) | [10.3](/filings/0001410578-25-001515.md) | [9.7](/filings/0001104659-26-086659.md) | [12.8](/filings/0001104659-26-086659.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/axr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ROBOTTI ROBERT](/funds/1105838.md) | 2026-06-30 | $13.2m | 521,765 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $5.0m | 197,258 | | Added +3,779 | | [Cerity Partners LLC](/funds/1566475.md) | 2026-06-30 | $4.2m | 167,642 | | Reduced −1,380 | | [Truffle Hound Capital, LLC](/funds/1595862.md) | 2026-06-30 | $4.0m | 160,000 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.6m | 144,042 | | Reduced −5,890 | | [JB CAPITAL PARTNERS LP](/funds/1138532.md) | 2026-06-30 | $3.6m | 141,360 | | Unchanged | | [Cresset Asset Management, LLC](/funds/1761013.md) | 2026-06-30 | $3.3m | 129,230 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $2.9m | 115,800 | | Reduced −3,400 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $2.8m | 111,423 | | Unchanged | | [Oppenheimer & Close, LLC](/funds/1591377.md) | 2026-06-30 | $1.7m | 66,950 | | Unchanged | ## Recent filings [All 543 filings](/companies/axr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-11 | 20:35 ET | [8-K](/filings/0001104659-26-107091.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-107091 | | 2026-09-11 | 20:30 ET | [10-Q](/filings/0001104659-26-107084.md) | Quarterly report, period 2026-07-31 | 0001104659-26-107084 | | 2026-08-04 | 20:30 ET | [DEF 14A](/filings/0001104659-26-090418.md) | Proxy statement, period 2026-09-10 | 0001104659-26-090418 | | 2026-07-24 | 20:32 ET | [8-K](/filings/0001104659-26-086664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-086664 | | 2026-07-24 | 20:30 ET | [10-K](/filings/0001104659-26-086659.md) | Annual report, period 2026-04-30 | 0001104659-26-086659 | | 2026-07-14 | 20:30 ET | [8-K](/filings/0001104659-26-083522.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-083522 | | 2026-06-24 | 21:28 ET | [SCHEDULE 13D/A](/filings/0001104659-26-077369.md) | Ownership report, active investor, amended | 0001104659-26-077369 | | 2026-03-12 | 20:35 ET | [8-K](/filings/0001104659-26-027103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-027103 | | 2026-03-12 | 20:30 ET | [10-Q](/filings/0001104659-26-027088.md) | Quarterly report, period 2026-01-31 | 0001104659-26-027088 | | 2026-02-13 | 21:18 ET | [SCHEDULE 13D/A](/filings/0001104659-26-015232.md) | Ownership report, active investor, amended | 0001104659-26-015232 | ## Latest annual report [Form 10-K for the fiscal year ended Apr 30, 2026](/filings/0001104659-26-086659.md), filed Jul 24, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 6207 - Tickers: AXR - Exchange: NYSE - SIC code: 6552 Land Subdividers & Developers (No Cemeteries) - State of incorporation: OK - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.